Maury K Harwood, MD
Orthopedic Surgery · Morgan Hill
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 25
- 5 carriers
- Office
- 1
On the public record
- Owns Morgan Hill Surgery Center, LP: Accreditation Lapsed
Offices
1 location
Hospitals listed: 058278 · 059796 · 757050 · Good Samaritan Hospital · Memorial Hospital Los Banos · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
25 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Harwood’s office at (408) 778-2663 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A79199 · Current
Licensed to practise in California · since 2002 · expires 2028-03-31 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Morgan Hill Surgery Center, LPAmbulatory Surgery Center · Morgan Hill, CA7.4% owner · accredited by AAAHCAccreditation Lapsed1 inspection · last 2012-08-03
- Forest Surgery Center LPAmbulatory Surgery Center · San Jose, CAOwner · accredited by JCAccreditation Renewed1 inspection, 1 with deficiencies · last 2012-09-18: Requirements Met
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Memorial Hospital Los BanosLos Banos, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Memorial Hospital Los Banos
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 48 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.46 to 1.43) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 14.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 33 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 324 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 797 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 753 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.95) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.76 (0.23 to 3.29) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.49 (0 to 1.69) · 573 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 86 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (9.8 to 18.5) · 59 cases | No different | Jan 2022 – Dec 2024 |
What patients said (172 patients answered, 12% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 80% |
| Yes, staff "did" give patients information about help after discharge | 75% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 82% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$302,689
Medicare paid this office $302,689 for 419 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 275 | $55,161 | $115 |
| Long return visit (40+ min) | 200 | $44,075 | $164 |
| Aspiration and/or injection of fluid from large joint | 182 | $33,955 | $60 |
| Replacement of knee joint, both sides of knee | 26 | $31,135 | $1,153 |
| Repair of shoulder rotator cuff using an endoscope | 21 | $20,241 | $964 |
See all 19 services
| Return visit (30+ min) | 275 | $55,161 | $115 |
| Long return visit (40+ min) | 200 | $44,075 | $164 |
| Aspiration and/or injection of fluid from large joint | 182 | $33,955 | $60 |
| Replacement of knee joint, both sides of knee | 26 | $31,135 | $1,153 |
| Repair of shoulder rotator cuff using an endoscope | 21 | $20,241 | $964 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 80 | $17,020 | None |
| New patient visit (60+ min) | 72 | $14,630 | $203 |
| New patient visit (45+ min) | 61 | $9,414 | $154 |
| Repair of knee joint with drilling and or scraping of joint using an endoscope | 11 | $6,850 | $623 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 28 | $4,158 | $148 |
| Short return visit (20+ min) | 34 | $4,147 | $81 |
| Removal of knee cartilage using an endoscope | 13 | $4,074 | $291 |
| Partial removal of collar bone at shoulder using an endoscope | 11 | $3,927 | $357 |
| Injection into tendon or ligament | 40 | $2,833 | $49 |
| Aspiration and/or injection of fluid from medium joint | 12 | $801 | $50 |
| Injection, methylprednisolone acetate, 1 mg | 138 | $767 | None |
| Injection of trigger points, 1-2 muscles | 12 | $702 | $47 |
| Injection into tendon at attachment to bone or muscle | 13 | $667 | $51 |
| Injection, methylprednisolone acetate, 40 mg | 73 | $434 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 35 | More than 69% of doctors who do this |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 42 | More than 98% of doctors who do this |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 43 | More than 83% of doctors who do this |
Who their Medicare patients are
419 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 11% · Women 62% · Also on Medicaid 5% · Health risk score 0.98. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Coronary heart disease 29% · Diabetes 26% · Chronic kidney disease 17% · Depression 17% · Atrial fibrillation 14% · Cancer 12% · Heart failure 10% · Stroke 9% · COPD 7% · Dementia 4%.
The office billed $840,527, Medicare allowed $389,519 and paid $302,689; for 10,063 services of 67 kinds; $19,869 of it was for drugs given in the office and $282,820 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 419 | 10,063 | 75 | 0.98 | $840,527 | $302,689 |
| 2023 | 374 | 2,331 | 74 | 0.91 | $695,644 | $259,729 |
| 2022 | 393 | 5,196 | 74 | 0.88 | $884,973 | $294,771 |
| 2021 | 373 | 6,287 | 75 | 0.92 | $774,025 | $301,085 |
| 2020 | 345 | 7,023 | 73 | 0.97 | $571,315 | $273,036 |
| 2019 | 377 | 7,410 | 74 | 1.01 | $691,797 | $283,528 |
| 2018 | 363 | 7,330 | 73 | 1.03 | $709,591 | $248,742 |
| 2017 | 346 | 3,369 | 73 | 0.94 | $573,435 | $185,142 |
| 2016 | 318 | 1,733 | 72 | 0.94 | $666,062 | $219,816 |
| 2015 | 322 | 1,901 | 72 | 0.98 | $622,934 | $204,295 |
| 2014 | 337 | 1,611 | 72 | 0.98 | $632,501 | $208,152 |
| 2013 | 332 | 1,445 | 71 | 0.95 | $680,579 | $228,911 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 258 | $57,223 | $115 |
| Aspiration and/or injection of fluid from large joint | 155 | $29,351 | $62 |
| Long return visit (40+ min) | 136 | $27,829 | $160 |
| Replacement of knee joint, both sides of knee | 17 | $20,281 | $1,127 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 73 | $16,363 | None |
| Repair of shoulder rotator cuff using an endoscope | 16 | $15,700 | $981 |
| New patient visit (45+ min) | 70 | $10,411 | $149 |
| New patient visit (60+ min) | 44 | $8,641 | $196 |
| Short return visit (20+ min) | 36 | $5,996 | $81 |
| Injection into tendon or ligament | 47 | $3,964 | $50 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 16 | $2,421 | $151 |
| Injection, methylprednisolone acetate, 40 mg | 139 | $1,637 | None |
| Aspiration and/or injection of fluid from medium joint | 17 | $1,017 | $48 |
2022: 17 services
| Return visit (30+ min) | 275 | $61,448 | $117 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 58 | $52,312 | None |
| Aspiration and/or injection of fluid from large joint | 152 | $24,589 | $61 |
| Replacement of knee joint, both sides of knee | 18 | $20,788 | $1,155 |
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 29 | $20,314 | None |
| Long return visit (40+ min) | 82 | $15,027 | $169 |
| Repair of shoulder rotator cuff using an endoscope | 16 | $14,567 | $910 |
| New patient visit (45+ min) | 73 | $10,395 | $142 |
| Short return visit (20+ min) | 107 | $10,164 | $66 |
| New patient visit (60+ min) | 33 | $6,746 | $204 |
| Injection into tendon or ligament | 33 | $3,029 | $43 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 17 | $2,895 | None |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 12 | $1,849 | $154 |
| Injection, methylprednisolone acetate, 40 mg | 139 | $1,410 | None |
| Aspiration and/or injection of fluid from medium joint | 14 | $937 | $55 |
| Injection of trigger points, 1-2 muscles | 11 | $785 | $49 |
| New patient visit (30+ min) | 11 | $674 | $61 |
2021: 14 services
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 76 | $113,170 | None |
| Short return visit (20+ min) | 260 | $46,283 | $85 |
| Replacement of knee joint, both sides of knee | 18 | $22,876 | $1,204 |
| Aspiration and/or injection of fluid from large joint | 148 | $22,404 | $62 |
| Return visit (30+ min) | 101 | $13,744 | $122 |
| Repair of shoulder rotator cuff using an endoscope | 12 | $12,464 | $959 |
| New patient visit (30+ min) | 119 | $11,723 | $99 |
| New patient visit (45+ min) | 15 | $2,323 | $155 |
| Injection into tendon or ligament | 27 | $2,265 | $48 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 14 | $2,097 | $150 |
| Injection, methylprednisolone acetate, 40 mg | 141 | $1,574 | None |
| Injection of trigger points, 1-2 muscles | 14 | $1,546 | $52 |
| Aspiration and/or injection of fluid from medium joint | 18 | $1,278 | $47 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 13 | $1,010 | None |
2020: 10 services
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 80 | $143,092 | None |
| Short return visit (20+ min) | 226 | $26,289 | $65 |
| Aspiration and/or injection of fluid from large joint | 155 | $22,553 | $62 |
| Return visit (30+ min) | 100 | $12,042 | $95 |
| Repair of shoulder rotator cuff using an endoscope | 11 | $10,997 | $1,000 |
| New patient visit (30+ min) | 72 | $6,564 | $91 |
| Injection into tendon or ligament | 38 | $2,631 | $40 |
| Injection, methylprednisolone acetate, 40 mg | 141 | $1,555 | None |
| Injection of trigger points, 1-2 muscles | 15 | $1,209 | $48 |
| Aspiration and/or injection of fluid from medium joint | 17 | $1,180 | $51 |
2019: 14 services
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 84 | $104,225 | None |
| Short return visit (20+ min) | 250 | $30,713 | $65 |
| Aspiration and/or injection of fluid from large joint | 176 | $24,902 | $56 |
| Replacement of knee joint, both sides of knee | 17 | $20,719 | $1,219 |
| Return visit (30+ min) | 137 | $17,761 | $91 |
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 13 | $17,457 | None |
| New patient visit (45+ min) | 51 | $7,157 | $140 |
| New patient visit (30+ min) | 48 | $4,711 | $98 |
| Injection into tendon or ligament | 40 | $2,500 | $43 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 13 | $1,452 | None |
| Injection, methylprednisolone acetate, 40 mg | 117 | $1,047 | None |
| Aspiration and/or injection of fluid from medium joint | 15 | $858 | $39 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 66 | $248 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $198 | $17 |
2018: 14 services
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 86 | $84,093 | None |
| Replacement of knee joint, both sides of knee | 23 | $28,550 | $1,142 |
| Short return visit (20+ min) | 228 | $24,202 | $60 |
| Aspiration and/or injection of fluid from large joint | 170 | $22,531 | $54 |
| Return visit (30+ min) | 116 | $14,296 | $91 |
| New patient visit (45+ min) | 61 | $7,276 | $119 |
| Repair of knee joint with drilling and or scraping of joint using an endoscope | 11 | $6,635 | $603 |
| New patient visit (30+ min) | 51 | $4,350 | $85 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 19 | $3,386 | None |
| Injection into tendon or ligament | 35 | $2,097 | $37 |
| Aspiration and/or injection of fluid from medium joint | 21 | $1,333 | $44 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 137 | $929 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 49 | $747 | $15 |
| Short return visit | 11 | $441 | $40 |
2017: 16 services
| Short return visit (20+ min) | 207 | $23,413 | $59 |
| Aspiration and/or injection of fluid from large joint | 154 | $21,935 | $52 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 26 | $18,870 | None |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 61 | $15,155 | None |
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 12 | $11,901 | None |
| Return visit (30+ min) | 75 | $8,067 | $91 |
| New patient visit (30+ min) | 91 | $7,620 | $84 |
| Repair of knee joint with drilling and or scraping of joint using an endoscope | 12 | $6,780 | $565 |
| New patient visit (45+ min) | 26 | $3,503 | $135 |
| Removal of knee cartilage using an endoscope | 13 | $3,009 | $231 |
| Injection into tendon or ligament | 34 | $1,939 | $40 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 11 | $1,741 | $145 |
| Aspiration and/or injection of fluid from medium joint | 15 | $769 | $40 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 53 | $752 | $14 |
| Injection, methylprednisolone acetate, 40 mg | 59 | $573 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 103 | $559 | None |
2016: 14 services
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 58 | $68,407 | None |
| Short return visit (20+ min) | 197 | $21,711 | $60 |
| Replacement of knee joint, both sides of knee | 15 | $17,540 | $1,169 |
| Aspiration and/or injection of fluid from large joint | 131 | $15,465 | $57 |
| Return visit (30+ min) | 88 | $9,784 | $87 |
| Long return visit (40+ min) | 40 | $4,877 | $119 |
| New patient visit (30+ min) | 60 | $4,338 | $72 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 16 | $3,377 | None |
| Injection into tendon or ligament | 40 | $3,050 | $43 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 15 | $2,168 | $145 |
| New patient visit (45+ min) | 14 | $1,783 | $127 |
| Injection, methylprednisolone acetate, 40 mg | 151 | $1,324 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 62 | $990 | $15 |
| Aspiration and/or injection of fluid from medium joint | 17 | $784 | $39 |
2015: 16 services
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 59 | $39,903 | None |
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 28 | $30,795 | None |
| Short return visit (20+ min) | 197 | $23,110 | $59 |
| Aspiration and/or injection of fluid from large joint | 142 | $17,559 | $56 |
| Replacement of knee joint, both sides of knee | 13 | $16,547 | $1,273 |
| Return visit (30+ min) | 70 | $7,929 | $94 |
| New patient visit (30+ min) | 61 | $5,498 | $90 |
| Injection into tendon or ligament | 43 | $3,604 | $46 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 11 | $3,416 | None |
| Long return visit (40+ min) | 29 | $3,289 | $113 |
| New patient visit (45+ min) | 15 | $2,059 | $137 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 12 | $1,804 | $150 |
| Injection, methylprednisolone acetate, 40 mg | 163 | $1,459 | None |
| Aspiration and/or injection of fluid from medium joint | 14 | $675 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 42 | $639 | $15 |
| Short return visit | 15 | $568 | $38 |
2014: 17 services
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 56 | $43,754 | None |
| Short return visit (20+ min) | 166 | $16,964 | $60 |
| Repair of shoulder rotator cuff using an endoscope | 16 | $15,030 | $939 |
| Aspiration and/or injection of fluid from large joint | 145 | $14,208 | $56 |
| Return visit (30+ min) | 96 | $13,108 | $93 |
| Replacement of knee joint, both sides of knee | 11 | $12,318 | $1,120 |
| Removal of knee cartilage using an endoscope | 11 | $5,366 | $488 |
| New patient visit (30+ min) | 63 | $5,103 | $81 |
| Long return visit (40+ min) | 36 | $5,096 | $131 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 11 | $3,228 | None |
| Injection into tendon or ligament | 34 | $2,206 | $42 |
| New patient visit (45+ min) | 16 | $2,153 | $135 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 14 | $2,108 | $151 |
| Injection, methylprednisolone acetate, 40 mg | 164 | $846 | None |
| Short return visit | 21 | $813 | $35 |
| Aspiration and/or injection of fluid from medium joint | 14 | $657 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $438 | $16 |
2013: 18 services
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 55 | $38,733 | None |
| Replacement of knee joint, both sides of knee | 17 | $23,044 | $1,356 |
| Replacement of thigh bone and hip joint with prosthesis | 13 | $18,516 | $1,323 |
| Repair of shoulder rotator cuff using an endoscope | 16 | $14,737 | $867 |
| Short return visit (20+ min) | 154 | $14,647 | $63 |
| Revision of component of total knee joint prosthesis | 12 | $12,369 | $1,031 |
| Aspiration and/or injection of fluid from large joint | 115 | $12,008 | $55 |
| Return visit (30+ min) | 82 | $10,899 | $90 |
| Long return visit (40+ min) | 55 | $7,071 | $122 |
| Removal of knee cartilage using an endoscope | 14 | $6,906 | $493 |
| New patient visit (30+ min) | 64 | $5,534 | $86 |
| New patient visit (45+ min) | 36 | $4,635 | $129 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 18 | $2,838 | $149 |
| Injection into tendon or ligament | 28 | $1,777 | $51 |
| Short return visit | 21 | $869 | $41 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 50 | $859 | $17 |
| Injection, methylprednisolone acetate, 40 mg | 119 | $618 | None |
| Aspiration and/or injection of fluid from small joint | 11 | $462 | $33 |
Drugs they prescribed that Part D paid
$7,955
Pharmacies billed $7,955 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 42% of their Part D prescriptions (283 of 675) in 2024. Above the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
673 generic and fewer than 11 brand-name prescriptions · $7,955 in drug cost · 53 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 157 | $1,583 | $10 |
| Oxycodone-Acetaminophen | 51 | $1,321 | $26 |
| Methylprednisolone | 70 | $384 | $5 |
| Celecoxib | 16 | $360 | $23 |
| Tramadol | 66 | $346 | $5 |
See all 12 drugs
| Hydrocodone-Acetaminophen | 157 | $1,583 | $10 |
| Oxycodone-Acetaminophen | 51 | $1,321 | $26 |
| Methylprednisolone | 70 | $384 | $5 |
| Celecoxib | 16 | $360 | $23 |
| Tramadol | 66 | $346 | $5 |
| Ibuprofen | 42 | $198 | $5 |
| Prednisone | 55 | $125 | $2 |
| Gabapentin | 16 | $124 | $8 |
| Meloxicam | 55 | $122 | $2 |
| Warfarin | 42 | $121 | $3 |
| Clindamycin | 17 | $88 | $5 |
| Amoxicillin | 13 | $10 | $1 |
Year by year
| 2024 | 675 | 231 | 42% (283) | None | $7,955 |
| 2023 | 672 | 192 | 45% (304) | None | $9,249 |
| 2022 | 626 | 175 | 43% (271) | None | $9,630 |
| 2021 | 653 | 161 | 50% (325) | None | $11,234 |
| 2020 | 834 | 184 | 48% (401) | 4% | $15,995 |
| 2019 | 841 | 217 | 42% (350) | 6% | $22,464 |
| 2018 | 918 | 213 | 45% (415) | 11% | $29,641 |
| 2017 | 810 | 176 | 54% (436) | 3% | $30,052 |
| 2016 | 754 | 155 | 56% (419) | 4% | $49,559 |
| 2015 | 693 | 146 | 53% (370) | 9% | $56,771 |
| 2014 | 716 | 174 | 48% (344) | 12% | $53,399 |
| 2013 | 638 | 168 | 47% (302) | 15% | $38,775 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Hydrocodone-Acetaminophen | 178 | $2,733 | $15 |
| Oxycodone-Acetaminophen | 55 | $1,041 | $19 |
| Celecoxib | 16 | $825 | $52 |
| Methylprednisolone | 64 | $702 | $11 |
| Diclofenac | 15 | $247 | $16 |
| Meloxicam | 64 | $230 | $4 |
| Tramadol | 64 | $227 | $4 |
| Warfarin | 40 | $201 | $5 |
| Gabapentin | 18 | $178 | $10 |
| Zolpidem | 20 | $144 | $7 |
| Prednisone | 32 | $140 | $4 |
| Ibuprofen | 18 | $124 | $7 |
| Clindamycin | 12 | $18 | $2 |
| Amoxicillin | 15 | $15 | $1 |
2022: 15 drugs
| Hydrocodone-Acetaminophen | 169 | $2,783 | $16 |
| Celecoxib | 29 | $1,337 | $46 |
| Oxycodone-Acetaminophen | 46 | $1,197 | $26 |
| Gabapentin | 52 | $532 | $10 |
| Methylprednisolone | 53 | $532 | $10 |
| Etodolac | 11 | $312 | $28 |
| Oxycodone | 15 | $237 | $16 |
| Alprazolam | 13 | $194 | $15 |
| Tramadol | 37 | $181 | $5 |
| Prednisone | 16 | $135 | $8 |
| Zolpidem | 14 | $114 | $8 |
| Warfarin | 24 | $84 | $4 |
| Ibuprofen | 11 | $74 | $7 |
| Meloxicam | 16 | $65 | $4 |
| Clindamycin | 15 | $30 | $2 |
2021: 14 drugs
| Hydrocodone-Acetaminophen | 237 | $4,478 | $19 |
| Diclofenac | 26 | $723 | $28 |
| Methylprednisolone | 80 | $664 | $8 |
| Celecoxib | 14 | $561 | $40 |
| Oxycodone-Acetaminophen | 25 | $559 | $22 |
| Gabapentin | 23 | $314 | $14 |
| Indomethacin | 18 | $310 | $17 |
| Carisoprodol | 19 | $275 | $14 |
| Cephalexin | 15 | $224 | $15 |
| Tramadol | 45 | $196 | $4 |
| Oxycodone | 14 | $181 | $13 |
| Ibuprofen | 22 | $130 | $6 |
| Warfarin | 21 | $77 | $4 |
| Meloxicam | 16 | $68 | $4 |
2020: 12 drugs
| Diclofenac | 153 | $4,748 | $31 |
| Hydrocodone-Acetaminophen | 292 | $4,030 | $14 |
| Oxycodone-Acetaminophen | 46 | $1,097 | $24 |
| Misoprostol | 11 | $556 | $51 |
| Etodolac | 20 | $544 | $27 |
| Methylprednisolone | 42 | $443 | $11 |
| Ibuprofen | 33 | $307 | $9 |
| Indomethacin | 20 | $250 | $12 |
| Tramadol | 43 | $188 | $4 |
| Acetaminophen-Codeine | 12 | $175 | $15 |
| Cyclobenzaprine | 11 | $127 | $12 |
| Clindamycin | 11 | $35 | $3 |
2019: 16 drugs
| Diclofenac | 136 | $4,758 | $35 |
| Hydrocodone-Acetaminophen | 238 | $3,455 | $15 |
| Etodolac | 29 | $1,369 | $47 |
| Oxycodone-Acetaminophen | 53 | $1,364 | $26 |
| Voltaren | 22 | $1,279 | $58 |
| Methylprednisolone | 86 | $1,059 | $12 |
| Celecoxib | 11 | $456 | $41 |
| Tramadol | 44 | $343 | $8 |
| Gabapentin | 23 | $262 | $11 |
| Ibuprofen | 23 | $230 | $10 |
| Indomethacin | 12 | $167 | $14 |
| Indomethacin Er | 12 | $146 | $12 |
| Ciprofloxacin | 12 | $99 | $8 |
| Warfarin | 16 | $62 | $4 |
| Clindamycin | 16 | $61 | $4 |
| Amoxicillin | 18 | $54 | $3 |
2018: 16 drugs
| Diclofenac | 136 | $4,941 | $36 |
| Hydrocodone-Acetaminophen | 184 | $4,181 | $23 |
| Oxycodone-Acetaminophen | 81 | $3,812 | $47 |
| Voltaren | 41 | $2,238 | $55 |
| Methylprednisolone | 92 | $1,317 | $14 |
| Oxycodone | 41 | $1,123 | $27 |
| Tramadol | 88 | $709 | $8 |
| Diazepam | 19 | $262 | $14 |
| Alprazolam | 21 | $185 | $9 |
| Ciprofloxacin | 19 | $143 | $8 |
| Prednisone | 11 | $135 | $12 |
| Acetaminophen-Codeine | 12 | $129 | $11 |
| Warfarin | 22 | $122 | $6 |
| Clindamycin | 15 | $121 | $8 |
| Ibuprofen | 12 | $86 | $7 |
| Amoxicillin | 15 | $46 | $3 |
2017: 15 drugs
| Oxycodone-Acetaminophen | 103 | $7,269 | $71 |
| Hydrocodone-Acetaminophen | 187 | $5,155 | $28 |
| Etodolac Er | 13 | $1,539 | $118 |
| Oxycodone | 43 | $1,106 | $26 |
| Methylprednisolone | 72 | $955 | $13 |
| Diclofenac | 22 | $915 | $42 |
| Voltaren | 13 | $685 | $53 |
| Tramadol | 77 | $508 | $7 |
| Etodolac | 15 | $488 | $33 |
| Clindamycin | 26 | $294 | $11 |
| Diazepam | 32 | $273 | $9 |
| Alprazolam | 35 | $269 | $8 |
| Ciprofloxacin | 11 | $74 | $7 |
| Warfarin | 12 | $59 | $5 |
| Amoxicillin | 16 | $45 | $3 |
2016: 15 drugs
| Hydrocodone-Acetaminophen | 248 | $10,470 | $42 |
| Pentazocine-Naloxone | 12 | $6,265 | $522 |
| Oxycodone-Acetaminophen | 46 | $3,406 | $74 |
| Oxycodone | 58 | $1,790 | $31 |
| Indomethacin | 15 | $1,073 | $72 |
| Diclofenac | 13 | $843 | $65 |
| Methylprednisolone | 44 | $778 | $18 |
| Zolpidem | 26 | $621 | $24 |
| Diazepam | 20 | $417 | $21 |
| Tramadol | 40 | $346 | $9 |
| Alprazolam | 25 | $257 | $10 |
| Clindamycin | 13 | $218 | $17 |
| Ibuprofen | 16 | $140 | $9 |
| Warfarin | 15 | $85 | $6 |
| Amoxicillin | 19 | $62 | $3 |
2015: 13 drugs
| Pennsaid | 12 | $16,796 | $1,400 |
| Hydrocodone-Acetaminophen | 221 | $9,346 | $42 |
| Oxycodone-Acetaminophen | 50 | $4,527 | $91 |
| Voltaren | 19 | $2,454 | $129 |
| Oxycodone | 40 | $1,487 | $37 |
| Etodolac Er | 12 | $1,143 | $95 |
| Methylprednisolone | 37 | $724 | $20 |
| Zolpidem | 28 | $484 | $17 |
| Ibuprofen | 12 | $104 | $9 |
| Tramadol | 19 | $87 | $5 |
| Diazepam | 15 | $87 | $6 |
| Naproxen | 13 | $81 | $6 |
| Amoxicillin | 23 | $37 | $2 |
2014: 17 drugs
| Pennsaid | 24 | $8,094 | $337 |
| Oxycodone-Acetaminophen | 53 | $5,519 | $104 |
| Lidocaine | 15 | $4,973 | $332 |
| Hydrocodone-Acetaminophen | 167 | $4,960 | $30 |
| Pentazocine-Naloxone | 17 | $4,852 | $285 |
| Voltaren | 23 | $2,120 | $92 |
| Oxycodone | 38 | $1,670 | $44 |
| Methylprednisolone | 38 | $820 | $22 |
| Methocarbamol | 12 | $757 | $63 |
| Etodolac | 17 | $536 | $32 |
| Zolpidem | 31 | $264 | $9 |
| Tramadol | 36 | $238 | $7 |
| Naproxen | 16 | $164 | $10 |
| Ibuprofen | 15 | $157 | $10 |
| Warfarin | 11 | $54 | $5 |
| Alprazolam | 13 | $50 | $4 |
| Amoxicillin | 15 | $37 | $2 |
2013: 14 drugs
| Pennsaid | 28 | $7,204 | $257 |
| Celebrex | 13 | $3,620 | $278 |
| Hydrocodone-Acetaminophen | 142 | $3,222 | $23 |
| Oxycodone Hcl-Acetaminophen | 33 | $2,459 | $75 |
| Oxycodone | 23 | $1,043 | $45 |
| Methylprednisolone | 41 | $1,001 | $24 |
| Tramadol | 50 | $501 | $10 |
| Etodolac | 23 | $437 | $19 |
| Diazepam | 11 | $141 | $13 |
| Ibuprofen | 14 | $127 | $9 |
| Zolpidem | 16 | $126 | $8 |
| Naproxen | 14 | $107 | $8 |
| Meloxicam | 12 | $56 | $5 |
| Amoxicillin | 11 | $35 | $3 |
Money from drug and device companies
$191 in 2025
| 2025 | 4 | 4 | None | $191 |
| 2023 | 1 | 1 | None | $21 |
| 2022 | 3 | 6 | None | $233 |
| 2021 | 1 | 3 | None | $62 |
| 2020 | 1 | 1 | None | $27 |
| 2019 | 4 | 5 | None | $72 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Aquamantys(Tm) | $120 | 1 payment
|
| Ethicon US | Vistaseal | $34 | 1 payment
|
| Stryker | Pangea | $20 | 1 payment
|
| Moximed | Misha Knee System, Small, Left | $17 | 1 payment
|
See all 4 published payments
| Stryker | Meals · 2025-12-11 | Pangea | $20 |
| Medtronic | Meals · 2025-08-28 | Aquamantys(Tm) | $120 |
| Moximed | Meals · 2025-08-06 | Misha Knee System, Small, Left | $17 |
| Ethicon US | Meals · 2025-08-01 | Vistaseal | $34 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $21
| Skeletal Dynamics | Geminus | $21 | 1 payment
|
2022: $233
| Smith+Nephew | Bone Anchors With Arthroscopic Delivery System | $157 | 4 payments
|
| Anika Therapeutics | Tactoset | $62 | 1 payment
|
| DePuy Synthes Sales | Peak | $14 | 1 payment
|
2021: $62
| Smith+Nephew | Regeneten Shoulder | $62 | 3 payments
|
2020: $27
| Vericel | Maci | $27 | 1 payment
|
2019: $72
| Arthrosurface | Hemicap Mtp Resurfacing | $25 | 2 payments
|
| Endo Pharmaceuticals | Xiaflex | $18 | 1 payment
|
| Bioventus | Durolane | $15 | 1 payment
|
| DePuy Synthes Sales | Monovisc | $14 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 61.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Breast cancer screeningEligible women who got a mammogram | 0%That's few of the people this applied to. | 324 |
| Colon cancer screeningEligible adults who got a colon cancer test | 0%That's few of the people this applied to. | 723 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 0%That's few of the people this applied to. | 1,169 |
| Medications listed in the chartVisits where the current medication list was documented | 0%That's few of the people this applied to. | 2,485 |
| Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS)As Medicare defines this measure | 0% | None |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 0%That's few of the people this applied to. | 1,115 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Invasive Procedure or Surgery Anticoagulation Medication Management
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
- Tobacco use
Professional record
- NPI
- 1043391352
- Licence
- CA A79199California A79199: Current · expires 2028-03-31
- Trained
- Tufts University School of Medicine, 1996
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A791990
- Taxonomy
- Federal specialty code 207XX0005X (207XX0005X)
- Mailing address
- 220 Standiford Ave, Suite F, Modesto, CA, 95350
- NPI first listed
- 2006-10-17
- NPI last updated
- 2018-01-24
This is when the NPI record was last certified, not a medical board exam.